Kensey Nash originally developed Angio-Seal, and St. Jude bought the marketing and manufacturing rights for the device from Tyco International in early 1999. "Angio-Seal will now be marketed by one of ...
En route to Abbott’s acquisition of St. Jude Medical, the duo is agreeing to sell off portions of their vascular and electrophysiology units, worth about $1.12 billion, to Terumo. The transaction is ...
SAN FRANCISCO (MarketWatch) -- Kensey Nash Corp. after Tuesday's closing bell said that it has executed a new supply contract with St. Jude Medical Inc. for the Angio-Seal vascular closure device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback